Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00447707 · ClinicalTrials.gov registry record · NA

Positive Choice: Prevention for Positive Health

A NA study of HIV Infections and Sexual Risk Behavior, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
497
Enrollment target
5
Study locations

NCT00447707 is a NA study of HIV Infections and Sexual Risk Behavior that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 497 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00447707, a NA study of HIV Infections and Sexual Risk Behavior, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
497 participants
Enrollment target
5
Study locations

Study Summary

This is a randomized, controlled trial of Positive Choice, an interactive multimedia computer program, to determine whether it can detect and reduce risky behaviors among HIV-positive adults. The behaviors of interest are: unprotected anal or vaginal intercourse, illicit drug use, risky alcohol drinking, and failure to disclose HIV status to sex partners. The Positive Choice program is integrated into the routine operations of outpatient HIV clinics, where participating patients complete an in-depth risk assessment (computerized health questionnaire) before a regularly scheduled medical appointment. Participants assigned to the intervention arm receive brief, interactive risk-reduction counseling by an actor-portrayed Video Doctor and an educational worksheet. Their health care provider receives as summary cueing sheet, alerting them to the patient's risky behavior and readiness to change. Control participants complete the computerized risk assessment and receive the clinic's usual care. Three months after a baseline visit, intervention and control group patients are invited back to complete an additional risk assessment. The intervention group also receives a "booster" intervention. Six months after baseline, both groups complete a final risk assessment.

Interventions

  • BEHAVIORAL Positive Choice

Study Locations (5)

California

  • Adult Immunology Clinic, Highland Hospital - Oakland
  • AIDS Project East Bay (APEB) - Oakland
  • East Bay AIDS Center (EBAC), Alta Bates Hospital - Oakland
  • Kaiser Permanente Medical Center - San Francisco
  • Adult Immunology Clinic, Fairmont Hospital - San Leandro

Trial Details

FieldValue
Enrollment Target 497 participants
Start Date 2003-12
Est. Completion 2006-09
Phase NA

What the Registry Record Tells You About NCT00447707

The ClinicalTrials.gov registry entry for NCT00447707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 497 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Positive Choice is the first listed.

NCT00447707 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00447707 about?

NCT00447707 is a clinical study titled "Positive Choice: Prevention for Positive Health". This is a randomized, controlled trial of Positive Choice, an interactive multimedia computer program, to determine whether it can detect and reduce risky behaviors among HIV-positive adults. The behaviors of interest are: unprotected anal or vaginal intercourse, illicit drug use, risky alcohol drin...

What is the current status of trial NCT00447707?

This trial is currently completed. It is a NA study. The enrollment target is 497 participants. The study started on 2003-12. Estimated completion is 2006-09.

What conditions does trial NCT00447707 study?

This clinical trial studies the following conditions: HIV Infections, Sexual Risk Behavior, Substance Use Risks.

What interventions are being tested in trial NCT00447707?

The interventions under investigation include: Positive Choice (BEHAVIORAL).

Who is sponsoring clinical trial NCT00447707?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00447707 being conducted?

This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.